Publications
5600 Results
- Journal / Conference
- New England Journal of Medicine Jul 12;379(2):111-121
- Year
- 2018
- Research Committee(s)
- Breast
- PMID
- PMID29860917
- PMC
- PMC6172658
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- Journal / Conference
- Cancer Feb 15;124(4):858-864. Epub 2017 Nov 7
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID29112232
- PMC
- PMC5801103
- Study Number(s)
- S9916
Estimating global treatment toxicity burden from adverse-event data
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 3603); ASCO 2018 Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Association of sex and adverse events (AEs) of adjuvant chemotherapy (ACT) in early stage colon cancer (CC): A pooled analysis of 28,636 patients (pts) in the ACCENT database
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 557); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Breast
CA15-3/MUC1 in CCTG MA.32: A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS3615); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/NRG-GI004
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/ bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 11500); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), oral
- Year
- 2018
Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105)
- Journal / Conference
- Journal of the National Cancer Institute Nov 1;110(11):1159-1160; Mar 14. doi: 10.1093/jnci/djy038. [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Cancer Control
- PMID
- PMID29547919
- PMC
- PMCIDPMC6454440
- Study Number(s)
- SWOG-9217
Reduced Risk of Prostate Cancer With 5a-Reductase Inhibitors. [Editorial]
- Journal / Conference
- Cold Spring Harbor Perspectives in Medicine Oct 1;8(10); 2018 Jan 8 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Cancer Control
- PMID
- PMID29311128
- PMC
- PMC6169981
- Study Number(s)
- SWOG-9217
Chemoprevention in Prostate Cancer: Current Perspective and Future Directions [Review]
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS598); ASCO Annual Meeting (June 1-5, 2018, Chicago), poster
- Year
- 2018
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/A011401
The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401)
- Journal / Conference
- European Urology Nov;74(5):585-594; Aug 1 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID30077399
- PMC
- PMC6195673
- Study Number(s)
- SWOG-9217